PeptiDream

4587.TPharmaceutical

Key numbers · FY ended 2025-12

Revenue¥18.5bn-60.3% YoY Operating income−¥5.0bn-123.7% YoY Net income (owners)−¥3.7bn-125.0% YoY Total assets¥77.0bn-17.0% YoY EPS (basic)¥-28.99-125.0% YoY

Full financial history and reports →

Stock price4587 · View chart ↗

Open the price chart on TradingView.

Latest filings

Thu, Feb 6 · JST1 filing

15:345% STAKEPeptiDream · Taiyo Pacific Partners L.P. · 5.11% → 3.90%−1.21pp

Fri, Jan 31 · JST1 filing

15:395% STAKEPeptiDream · Taiyo Pacific Partners L.P. · 6.18% → 5.11%−1.07pp

Wed, Nov 6 · JST1 filing

15:115% STAKEPeptiDream · Taiyo Pacific Partners L.P. · 7.20% → 6.18%−1.02pp

All filings →

Major holders (5%+) · 2

Holder	Stake	Change	Filed
M&G Investment Management Limited	9.54%	+1.04pp	2026-03-23
M&G Investments (Singapore) Pte. Ltd.	9.54%	+1.04pp	2026-03-23

Each holder's own ratio from its most recent large-shareholding report.